Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $2.6 million.

  • Utah Medical Products' Income from Continuing Operations fell 2615.77% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 2383.01%. This contributed to the annual value of $13.5 million for FY2024, which is 1548.64% down from last year.
  • Utah Medical Products' Income from Continuing Operations amounted to $2.6 million in Q3 2025, which was down 2615.77% from $3.0 million recorded in Q2 2025.
  • Over the past 5 years, Utah Medical Products' Income from Continuing Operations peaked at $4.3 million during Q4 2023, and registered a low of $2.6 million during Q3 2025.
  • Over the past 5 years, Utah Medical Products' median Income from Continuing Operations value was $3.9 million (recorded in 2023), while the average stood at $3.7 million.
  • Per our database at Business Quant, Utah Medical Products' Income from Continuing Operations soared by 16092.92% in 2021 and then tumbled by 3229.12% in 2024.
  • Quarter analysis of 5 years shows Utah Medical Products' Income from Continuing Operations stood at $4.1 million in 2021, then dropped by 0.56% to $4.1 million in 2022, then rose by 4.31% to $4.3 million in 2023, then tumbled by 32.29% to $2.9 million in 2024, then decreased by 9.34% to $2.6 million in 2025.
  • Its Income from Continuing Operations stands at $2.6 million for Q3 2025, versus $3.0 million for Q2 2025 and $3.0 million for Q1 2025.